As of 7 March 2025, the Therapeutic Goods Administration (TGA) has introduced updated regulations prohibiting the use of terms such as “anti-wrinkle” and “dermal fillers” in advertising. These changes apply to all cosmetic injectable services that involve Schedule 4 prescription medications.

Due to these regulatory requirements, we are unable to advertise specific treatments or provide pricing details publicly. We understand this may be frustrating, but please know that this is not an attempt to be vague or unhelpful. We are committed to full transparency while remaining compliant with current laws.

To ensure your safety and satisfaction, we offer a comprehensive in-person consultation followed by a Telehealth consultation with a prescribing practitioner. Your personalised treatment plan, including all available options and pricing, will be provided at this stage.

We appreciate your understanding and continued support as we navigate these changes in line with TGA regulations.